［1］Michele Orditura,Gennaro Galizia,Vincenzo Sforza.Treatment of gastric cancer［J］.World J Gastroenterol,2014,20(7):1635-1649.
[2]Ying Wu,Zhewei Wei,Yulong He,et al.Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer［J］.World J Gastroenterol,2013,19(21):3309-3315.
[3]Maki Yamamoto,Omar M Rashid,Joyce Wong.Surgical management of gastric cancer:The East vs.West perspective［J］.J Gastrointest Oncol,2015,6(1):79-88.
[4]Zhang ZS，Xue CN，Zhang J.Intraperitoneal hyperthermal chemotherapy with cisplatin combined with capecitabine in the treatment for ascites in patients with advanced gastric carcinoma［J］.J Practical Med,2012,28(20):3447-3449.［张自森,薛长年,张剑.腹腔热灌注顺铂联合卡陪他滨治疗晚期胃癌腹腔积液［J］.实用内科杂志,2012,28(20):3447-3449.］
[5]Wilson L Costa Jr,Felipe JF Coimbra,Ribeiro HS，et al.Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients［J］.World J Surg Oncol,2012,10(1):11-12.
[6]Liu YB,Liu W,Hong L.Observation and analysis of toxic and side effect of continuous hyperthermic peritoneal perfusion chemotherapy［J］.Chin J Bases and Clinics General Surg,2010,17(3):237-239.［刘义冰,刘巍,洪雷.腹腔热灌注化疗毒副作用的观察和分析［J］.中国普外基础和临床杂志,2010,17(3):237-239.］
[7]Zhang Mingzhi,Wu Kongming,Han Xinwei.The new development of cancer treatment［M］.Beijing:China Medical Science Press，1994:125-130.［张明智,吴孔明,韩新巍.恶性肿瘤治疗新进展［M］.北京:中国医学科技出版社,1994:125-130.］
[8]Qin ZF,Wei PK,Li J,et al.Effect of Kanglaite injection combined with Chinese drug therapy according to syndrome differentiation on puality of life and immune function in patients with advanced lung cancer［J］.Chin J Integrated Traditional and Western Med,2002,22(8):618-619.［秦志丰,魏品康,李峻,等.康莱特注射液结合中医辨证对晚期肺癌生存质量及免疫功能的影响［J］.中国中西医结合杂志,2002,22(8):618-619.］
[9]Zhang YH,Qi ZP,Zhang RJ.Clinical observation of intraperitoneal hyperthermic perfusion of Kanglaite combined with FOLFOX6 chemotherapy for local advanced gastric cancer［J］.J Shanxi Med University,2014,45(5):382-384.［张永红,齐增平,张瑞娟.康莱特腹腔热灌注联合FOLFOX6化疗方案治疗局部晚期胃癌的临床观察［J］.山西医科大学学报,2014,45(5):382-384.］
[10]Xu XX,Zhang W,Wen AP.Clinical observation of intraperitoneal hyperthermic perfusion of Kanglaite combined with chemotherapy for advanced gastric cancer［J］.China Pharmacist,2011,14(8):1179-1180.［徐学新,张炜,温爱萍.康莱特腹腔热灌注联合化疗治疗晚期胃癌的临床观察［J］.中国药师,2011,14(8):1179-1180.］
[11]Wen AP,Zhang XF,Wei CH.Efficacy of intraperitoneal hyperthermic perfusion of Kanglaite combined with intravenous chemotherapy for advanced gastric cancer［J］.Hebei Med J,2013,35(23):3590-3592.［温爱萍,张秀芬,魏朝辉.康莱特腹腔热灌注联合静脉化疗治疗中晚期胃癌的效果观察［J］.河北医药,2013,35(23):3590-3592.］
[12]Wang TY,Meng Q,Sun CQ.Clinical observation of Kanglaite combined with intraperitoneal hyperthermic chemotherapy for malignant ascites［J］.Chin J Clinicians(Electronic Edition),2012,6(13):3799-3800.［王太勇,孟琦,孙长青.康莱特联合腹腔热灌注化疗治疗恶性腹水的临床观察［J］.中华临床医师杂志(电子版),2012,6(13):3799-3800.］
[13]Sun Lei.Efficacy of perfusion chemotherapy of kang-lai-te injection with cisplatin for malignant ascites［J］.Modern Oncology,2011,19(9):1820-1822.［孙雷.康莱特联合顺铂热灌注化疗治疗恶性腹腔积液的疗效观察［J］.现代肿瘤医学,2011,19(9):1820-1822.］
[14]He Anbing,Liu Yanping.Clinical obervation of intrapleural injection of Kanglaite in the treatment of malignant pleural effusion［J］.Modern Oncology,2009,17(8):1497-1498.［何安兵,刘艳屏.康莱特腔内注射治疗恶性胸腔积液的临床观察［J］.现代肿瘤医学，2009,17(8):1497-1498.］
[15]Hiromichi Maeda,Michiya Kobayashi,Junichi Sakamoto.Evaluation and treatment of malignant ascites secondary to gastric cancer［J］.World J Gastroenterol,2015,21(39):10936-10947.